BRPI1009435A2 - tratamento para câncer no pâncreas - Google Patents

tratamento para câncer no pâncreas

Info

Publication number
BRPI1009435A2
BRPI1009435A2 BRPI1009435A BRPI1009435A BRPI1009435A2 BR PI1009435 A2 BRPI1009435 A2 BR PI1009435A2 BR PI1009435 A BRPI1009435 A BR PI1009435A BR PI1009435 A BRPI1009435 A BR PI1009435A BR PI1009435 A2 BRPI1009435 A2 BR PI1009435A2
Authority
BR
Brazil
Prior art keywords
pancreatic cancer
cancer treatment
treatment
pancreatic
cancer
Prior art date
Application number
BRPI1009435A
Other languages
English (en)
Inventor
Mark S Chapman
Original Assignee
Ardea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42129806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1009435(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc
Publication of BRPI1009435A2 publication Critical patent/BRPI1009435A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI1009435A 2009-03-11 2010-03-11 tratamento para câncer no pâncreas BRPI1009435A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15939709P 2009-03-11 2009-03-11
PCT/US2010/027021 WO2010105082A1 (en) 2009-03-11 2010-03-11 Treatment of pancreatic cancer

Publications (1)

Publication Number Publication Date
BRPI1009435A2 true BRPI1009435A2 (pt) 2016-03-01

Family

ID=42129806

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009435A BRPI1009435A2 (pt) 2009-03-11 2010-03-11 tratamento para câncer no pâncreas

Country Status (20)

Country Link
US (1) US20120053211A1 (pt)
EP (1) EP2405907A1 (pt)
JP (1) JP2012520319A (pt)
KR (1) KR20110128916A (pt)
CN (1) CN102438609A (pt)
AU (1) AU2010224108A1 (pt)
BR (1) BRPI1009435A2 (pt)
CA (1) CA2754891A1 (pt)
CL (1) CL2011002234A1 (pt)
CR (1) CR20110478A (pt)
EA (1) EA201101305A1 (pt)
IL (1) IL215037A0 (pt)
MA (1) MA33109B1 (pt)
MX (1) MX2011009494A (pt)
SG (1) SG174271A1 (pt)
SV (1) SV2011004017A (pt)
TN (1) TN2011000456A1 (pt)
TW (1) TW201100081A (pt)
UY (1) UY32486A (pt)
WO (1) WO2010105082A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20121471A1 (es) 2009-11-04 2012-11-01 Novartis Ag Derivados de sulfonamida heterociclicos utiles como inhibidores de mek
AU2013337702A1 (en) 2012-11-02 2015-05-21 Merck Patent Gmbh Method of reducing adverse effects in a cancer patient undergoing treatment with a MEK inhibitor
CN103267852B (zh) * 2013-05-15 2015-03-25 中国医学科学院北京协和医院 成纤维激活蛋白α在制备胰腺癌预后试剂盒中的用途
ES2957388T3 (es) * 2016-07-15 2024-01-18 H2 Water Tech Ltd Composición para producir agua rica en hidrógeno
KR101980809B1 (ko) * 2017-09-29 2019-05-21 대한민국 귀리껍질 추출물을 포함하는 췌장암의 예방 또는 치료용 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8005A (en) * 1851-04-01 He ne y bo o t
US9022A (en) * 1852-06-15 Organ
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
ATE483463T1 (de) * 2006-04-18 2010-10-15 Ardea Biosciences Inc Pyridonsulfonamide und pyridonsulfamide als mek- hemmer
MX2010001244A (es) * 2007-07-30 2010-08-31 Ardea Biosciences Inc Derivados de n-(arilamino) sulfonamidas que incluyen polimorfos como inhibidores de mek asi como composiciones, metodos de uso y de preparacion de los mismos.
US8044240B2 (en) * 2008-03-06 2011-10-25 Ardea Biosciences Inc. Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof

Also Published As

Publication number Publication date
SV2011004017A (es) 2012-01-06
JP2012520319A (ja) 2012-09-06
MA33109B1 (fr) 2012-03-01
UY32486A (es) 2010-10-29
MX2011009494A (es) 2011-10-11
AU2010224108A1 (en) 2011-09-22
WO2010105082A1 (en) 2010-09-16
CL2011002234A1 (es) 2012-01-27
EP2405907A1 (en) 2012-01-18
KR20110128916A (ko) 2011-11-30
TN2011000456A1 (en) 2013-03-27
CA2754891A1 (en) 2010-09-16
US20120053211A1 (en) 2012-03-01
IL215037A0 (en) 2011-11-30
CR20110478A (es) 2011-10-24
EA201101305A1 (ru) 2012-04-30
SG174271A1 (en) 2011-10-28
CN102438609A (zh) 2012-05-02
TW201100081A (en) 2011-01-01

Similar Documents

Publication Publication Date Title
BR112012005594A2 (pt) tratamento de câncer
BRPI1013618A2 (pt) pirimidinas substituídas para o tratamento de câncer
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
ATE526024T1 (de) Fluvoxamin vermeidende pirfenidontheraphy
HK1175476A1 (en) Cancer treatment
DK2473510T3 (da) Jak-2-hæmmere og anvendelse heraf til behandling af myeloproliferativesygdomme og cancer
BRPI0810206A2 (pt) Método de tratar câncer
BRPI1010874A2 (pt) composição para o tratamento de câncer de próstata
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
BR112012000502A2 (pt) terapia de combinação para o tratamento de diabetes
BRPI1006438A2 (pt) terapia adjuvante de cancer
BRPI1008566A8 (pt) métodos e composições para o diagnóstico e tratamento de câncer
BRPI1007995A2 (pt) orto-aminoamidas para o tratamento de cãncer.
BR112012002797A2 (pt) tratamento de câncer de próstata
BRPI1009919A2 (pt) combinações de pentamidina para tratamento de câncer.
BR112012002269A2 (pt) implemento para tratar superfície
BRPI1008564A2 (pt) métodos e composições para o dignóstico e tratamento de câncer
BRPI0922884A2 (pt) compostos para tratamento de câncer
BRPI0908715A2 (pt) métodos para tratamento da psoríase
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BR112013011659A2 (pt) métodos de tratamento do câncer
BRPI0909016A2 (pt) anticorpos úteis para o tratamento do câncer
HK1163524A1 (zh) 胰腺腫瘤治療
BRPI0922367A2 (pt) enzastaurin para o tratamento de câncer

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]